Drugmaker AstraZeneca and skincare product developer Galderma announced that they will collaborate on R&D for new dermatological treatments based on AstraZeneca's compounds. Notably, the collaboration will target relatively mild skin...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)